Sponsor Pipeline

LimmaTech Biologics AG Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16

Active Trials

Recruiting

What Changed in the Last 30 Days

First Posted	New Trial Filing	Phase	Status
2026-08-11	NCT07758972 Safety and Immunogenicity Study of a Multivalent Gonorrhoea Vaccine	Phase 1	Recruiting

Active Trials by Phase

Phase 2

Phase 1/2

Phase 1

Active Trials

NCT ID	Title	Condition	Status
Phase 2
NCT06615375	A Human Challenge Study to Assess Protection of a Shigella Tetravalent Bioconjugate…	Shigellosis	Active, Not Recruiting
Phase 1/2
NCT06190509	Assessing the Safety, Immune Response, and Early Efficacy of a Candida Vaccine in Women…	Recurrent Vulvovaginal Candidiasis	Active, Not Recruiting
Phase 1
NCT07758972	Safety and Immunogenicity Study of a Multivalent Gonorrhoea Vaccine	Neisseria Gonorrhea	Recruiting

Get alerts when LimmaTech Biologics AG's trials change

Status changes, date slips, and new filings — detected daily, delivered to your inbox.